Gilead Sciences, Inc. NASDAQ:GILD

Gilead Sciences stock price today

$117.6
+23.48
+24.96%
Financial Health
0
1
2
3
4
5
6
7
8
9

Gilead Sciences stock price monthly change

+34.52%
month

Gilead Sciences stock price quarterly change

+34.52%
quarter

Gilead Sciences stock price yearly change

+17.10%
year

Gilead Sciences key metrics

Market Cap
114.84B
Enterprise value
135.49B
P/E
931.39
EV/Sales
4.78
EV/EBITDA
34.57
Price/Sales
4.14
Price/Book
6.35
PEG ratio
440.08
EPS
0.4
Revenue
27.45B
EBITDA
10.82B
Income
484M
Revenue Q/Q
5.25%
Revenue Y/Y
1.50%
Profit margin
0.45%
Oper. margin
29.63%
Gross margin
77.98%
EBIT margin
29.63%
EBITDA margin
39.44%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Gilead Sciences stock price history

Gilead Sciences stock forecast

Gilead Sciences financial statements

Average Price Target
Last Year

$87.18

Potential downside: -25.86%

Based on estimate of 8 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Gilead Sciences, Inc. (NASDAQ:GILD): Profit margin
Jun 2023 6.59B 1.04B 15.84%
Sep 2023 7.05B 2.18B 30.92%
Dec 2023 7.11B 1.42B 20.08%
Mar 2024 6.68B -4.17B -62.37%
3.27%
Yield TTM
Gilead Sciences, Inc. (NASDAQ:GILD): Payout ratio
Payout ratio 3862.7%
Gilead Sciences, Inc. (NASDAQ:GILD): Dividend Yield
2019 3.9%
2020 4.71%
2021 3.95%
2022 3.44%
2023 3.77%
Gilead Sciences, Inc. (NASDAQ:GILD): Debt to assets
Jun 2023 62337000000 41.24B 66.16%
Sep 2023 62373000000 40.13B 64.34%
Dec 2023 62125000000 39.37B 63.38%
Mar 2024 56292000000 38.83B 68.99%
Gilead Sciences, Inc. (NASDAQ:GILD): Cash Flow
Jun 2023 2.33B -483M -1.10B
Sep 2023 1.75B -229M -1.51B
Dec 2023 2.16B -727M -1.09B
Mar 2024 2.21B -2.20B -1.36B

Gilead Sciences alternative data

Gilead Sciences Social Media Accounts

What are followers?
Gilead Sciences, Inc. (NASDAQ:GILD): Followers count
Sep 2023 25711
Gilead Sciences, Inc. (NASDAQ:GILD): Followers count
May 2025 13842
Jul 2025 14681
Aug 2025 15105

Areas of Focus

Gilead Sciences, Inc. (NASDAQ:GILD): Google Trends - Areas of Focus
19 Feb 2023 4600
26 Feb 2023 4501
5 Mar 2023 4700
12 Mar 2023 4700
19 Mar 2023 5000
26 Mar 2023 4901
2 Apr 2023 4901
9 Apr 2023 5101
16 Apr 2023 5201
23 Apr 2023 4901
30 Apr 2023 5001
7 May 2023 4501
14 May 2023 4401
21 May 2023 4901
28 May 2023 5001
4 Jun 2023 5101
11 Jun 2023 6801
18 Jun 2023 5900
25 Jun 2023 5800
2 Jul 2023 4700

Gilead Sciences

Gilead Sciences, Inc. (NASDAQ:GILD): Google Trends - Gilead Sciences
21 May 2023 7
28 May 2023 8
4 Jun 2023 6
11 Jun 2023 6
18 Jun 2023 5
25 Jun 2023 8
2 Jul 2023 5
9 Jul 2023 7
16 Jul 2023 10
23 Jul 2023 6
30 Jul 2023 12
6 Aug 2023 8
13 Aug 2023 5
20 Aug 2023 5
27 Aug 2023 5
3 Sep 2023 3
10 Sep 2023 5
17 Sep 2023 5
24 Sep 2023 3
1 Oct 2023 4

Gilead Sciences Covid-19 Product

Gilead Sciences, Inc. (NASDAQ:GILD): Google Trends - Gilead Sciences Covid-19 Product
4 Aug 2024 10
11 Aug 2024 7
18 Aug 2024 9
25 Aug 2024 12
1 Sep 2024 10
8 Sep 2024 11
15 Sep 2024 11
22 Sep 2024 18
29 Sep 2024 31
6 Oct 2024 29
13 Oct 2024 100
20 Oct 2024 56
27 Oct 2024 45
3 Nov 2024 43
10 Nov 2024 42
17 Nov 2024 32
24 Nov 2024 30
1 Dec 2024 31
8 Dec 2024 26
15 Dec 2024 21

Gilead Sciences HIV Products

Gilead Sciences, Inc. (NASDAQ:GILD): Google Trends - Gilead Sciences HIV Products
4 Aug 2024 4085509
11 Aug 2024 3973608
18 Aug 2024 42728010
25 Aug 2024 4072709
1 Sep 2024 41641010
8 Sep 2024 4895509
15 Sep 2024 42633010
22 Sep 2024 4272308
29 Sep 2024 4663007
6 Oct 2024 4382907
13 Oct 2024 47546010
20 Oct 2024 3753609
27 Oct 2024 3952707
3 Nov 2024 4582607
10 Nov 2024 4862408
17 Nov 2024 3672208
24 Nov 2024 4562608
1 Dec 2024 45628010
8 Dec 2024 4373308
15 Dec 2024 4052706

Gilead Sciences Oncology Products

Gilead Sciences, Inc. (NASDAQ:GILD): Google Trends - Gilead Sciences Oncology Products
19 Feb 2023 1837320
26 Feb 2023 1317250
5 Mar 2023 1625330
12 Mar 2023 1624287
19 Mar 2023 521215
26 Mar 2023 8100297
2 Apr 2023 1246350
9 Apr 2023 734170
16 Apr 2023 23122413
23 Apr 2023 527326
30 Apr 2023 1817270
7 May 2023 1432295
14 May 2023 920273
21 May 2023 1229259
28 May 2023 1033125
4 Jun 2023 016197
11 Jun 2023 1226157
18 Jun 2023 3530307
25 Jun 2023 1628240
2 Jul 2023 7242014

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Gilead Sciences, Inc. (NASDAQ:GILD): Job openings
Sep 2023 283
Oct 2023 365
Nov 2023 389
Dec 2023 345
Jan 2024 356
Feb 2024 334
Apr 2024 331
May 2024 308
Jun 2024 296
Jul 2024 299
Dec 2024 410
Jan 2025 487
Feb 2025 426
May 2025 360
Jul 2025 327
Aug 2025 277
Gilead Sciences, Inc. (NASDAQ:GILD): Employee count
Sep 2023 17,000
Oct 2023 17,000
Nov 2023 17,000
Dec 2023 17,000
Jan 2024 17,000
Feb 2024 17,000
Apr 2024 18,000
May 2024 18,000
Jun 2024 18,000
Jul 2024 18,000

Gilead Sciences other data

77.29% -2.56%
of GILD is owned by hedge funds
975.42M -32.27M
shares is hold by hedge funds

Gilead Sciences, Inc. (NASDAQ:GILD): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 10230
Apr 2024 0 2000
Jul 2024 0 2000
Aug 2024 0 15003
Sep 2024 0 50603
Oct 2024 0 2000
Nov 2024 0 450234
Transaction Date Insider Security Shares Price per share Total value Source
Option
PATTERSON SANDRA officer: SVP, Controllership
Common Stock 157 N/A N/A
Option
PATTERSON SANDRA officer: SVP, Controllership
Restricted Stock Unit 157 N/A N/A
Option
PATTERSON SANDRA officer: SVP, Controllership
Common Stock 901 N/A N/A
Option
PATTERSON SANDRA officer: SVP, Controllership
Restricted Stock Unit 901 N/A N/A
Option
PARSEY MERDAD officer: Chief Me.. Common Stock 3,820 N/A N/A
Option
MERCIER JOHANNA officer: Chief Co.. Restricted Stock Unit 3,752 N/A N/A
Option
DICKINSON ANDREW D officer: Chief Fi.. Common Stock 3,640 N/A N/A
Option
DICKINSON ANDREW D officer: Chief Fi.. Restricted Stock Unit 3,640 N/A N/A
Option
TELMAN DEBORAH H officer: EVP, Corporate Affairs..
Restricted Stock Unit 639 N/A N/A
Option
TELMAN DEBORAH H officer: EVP, Corporate Affairs..
Common Stock 639 N/A N/A
Patent
Application
Filling date: 27 Jan 2022 Issue date: 8 Sep 2022
Application
Filling date: 16 Feb 2022 Issue date: 1 Sep 2022
Application
Filling date: 26 Jan 2022 Issue date: 25 Aug 2022
Grant
Filling date: 6 May 2021 Issue date: 23 Aug 2022
Grant
Filling date: 14 Oct 2020 Issue date: 23 Aug 2022
Grant
Filling date: 20 May 2020 Issue date: 23 Aug 2022
Application
Filling date: 17 Jul 2020 Issue date: 18 Aug 2022
Application
Filling date: 11 Jun 2020 Issue date: 18 Aug 2022
Grant
Filling date: 6 May 2021 Issue date: 16 Aug 2022
Application
Filling date: 26 Jan 2022 Issue date: 11 Aug 2022
Sunday, 29 December 2024
seekingalpha.com
Thursday, 26 December 2024
zacks.com
Tuesday, 24 December 2024
schaeffersresearch.com
Friday, 20 December 2024
businesswire.com
zacks.com
Thursday, 19 December 2024
investorplace.com
Wednesday, 18 December 2024
zacks.com
zacks.com
seekingalpha.com
Tuesday, 17 December 2024
zacks.com
businesswire.com
businesswire.com
Monday, 16 December 2024
zacks.com
zacks.com
Friday, 13 December 2024
businesswire.com
Thursday, 12 December 2024
reuters.com
businesswire.com
zacks.com
zacks.com
Monday, 9 December 2024
businesswire.com
businesswire.com
Sunday, 8 December 2024
businesswire.com
Wednesday, 4 December 2024
seekingalpha.com
zacks.com
Tuesday, 3 December 2024
seekingalpha.com
zacks.com
Friday, 29 November 2024
zacks.com
zacks.com
Thursday, 28 November 2024
zacks.com
Wednesday, 27 November 2024
businesswire.com
  • What's the price of Gilead Sciences stock today?

    One share of Gilead Sciences stock can currently be purchased for approximately $117.6.

  • When is Gilead Sciences's next earnings date?

    Unfortunately, Gilead Sciences's (GILD) next earnings date is currently unknown.

  • Does Gilead Sciences pay dividends?

    Yes, Gilead Sciences pays dividends and its trailing 12-month yield is 3.27% with 3863% payout ratio.It means that the company is paying a dividend greater than earnings. The last Gilead Sciences stock dividend of $0.71 was paid on 30 Dec 2021.

  • How much money does Gilead Sciences make?

    Gilead Sciences has a market capitalization of 114.84B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.6% to 27.12B US dollars.

  • What is Gilead Sciences's stock symbol?

    Gilead Sciences, Inc. is traded on the NASDAQ under the ticker symbol "GILD".

  • What is Gilead Sciences's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - General industry.

  • How do i buy shares of Gilead Sciences?

    Shares of Gilead Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Gilead Sciences's key executives?

    Gilead Sciences's management team includes the following people:

    • Mr. Daniel P. O'Day Chairman & Chief Executive Officer(age: 61, pay: $7,480,000)
    • Ms. Johanna Mercier Chief Commercial Officer(age: 55, pay: $4,860,000)
    • Dr. Merdad V. Parsey M.D., Ph.D. Chief Medical Officer(age: 62, pay: $3,850,000)
    • Mr. Brett A. Pletcher Executive Vice President of Corporation Affairs, Gen. Counsel & Corporation Sec.(age: 57, pay: $2,710,000)
    • Mr. Andrew D. Dickinson Executive Vice President & Chief Financial Officer(age: 55, pay: $2,710,000)
  • How many employees does Gilead Sciences have?

    As Jul 2024, Gilead Sciences employs 18,000 workers.

  • When Gilead Sciences went public?

    Gilead Sciences, Inc. is publicly traded company for more then 33 years since IPO on 22 Jan 1992.

  • What is Gilead Sciences's official website?

    The official website for Gilead Sciences is gilead.com.

  • Where are Gilead Sciences's headquarters?

    Gilead Sciences is headquartered at 333 Lakeside Drive, Foster City, CA.

  • How can i contact Gilead Sciences?

    Gilead Sciences's mailing address is 333 Lakeside Drive, Foster City, CA and company can be reached via phone at +65 05743000.

  • What is Gilead Sciences stock forecast & price target?

    Based on 8 Wall Street analysts` predicted price targets for Gilead Sciences in the last 12 months, the avarage price target is $87.18. The average price target represents a -25.86% change from the last price of $117.6.

Gilead Sciences company profile:

Gilead Sciences, Inc.

gilead.com
Exchange:

NASDAQ

Full time employees:

18,000

Industry:

Drug Manufacturers - General

Sector:

Healthcare

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

333 Lakeside Drive
Foster City, CA 94404

CIK: 0000882095
ISIN: US3755581036
CUSIP: 375558103